English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Yaremenko L.M., Вidna L.P., Shepelev S.Ye., Grabovyi O.M.

    REACTION OF IBA-1-POSITIVE MICROGLIA CELLS IN THE SENSORIMOTOR CORTEX OF RATS WITH INDUCTION OF TRANSIENT ISCHEMIA


    About the author: Yaremenko L.M., Вidna L.P., Shepelev S.Ye., Grabovyi O.M.
    Heading EXPERIMENTAL MEDICINE
    Type of article Scentific article
    Annotation In order to study the peculiarities of the reaction of iba-1-positive microglia cells in the cortex of rats with induction of transient ischemia against the background of previous sensitization by the brain antigen and the resulting changes, an experiment was carried out on 135 white mature male rats weighing 260-290 grams histological, immunohistochemical, morphometric and statistical methods of investigation have been applied. It has been established that sensitization by brain antigen leads to neurodegenerative changes in the cerebral cortex and, after a period of insignificant decrease, to an increase in the number of Iba-1 + -microglia cells and their hypertrophy, which can be treated as a neuroinflammation. Sensitization by brain antigen potentiates the reaction (increase in the specific amount) of microglia to a transient circulatory disturbance. Immunomodulator imunofan reduces the reaction of Iba-1 + -microglia in the recovery period after transient ischemia. This correlates with a more favorable course of the post ischemic process as a whole. The latter can be considered as a manifestation of the neuroprotective properties of imunophane.
    Tags brain, sensitization, ischemia, Iba-1, microglia, imunophane
    Bibliography
    • Belozertsev YuA, Yuntsev SV. Issledovaniye neyroprotektornogo i nootropnogo deystviya preparatov pri patologii TSNS. Zabayk. med. vest. 2008; 2: 42-45. [in Russian]
    • Hrabovyi OM, Yaremenko LM. Sposib modelyuvannya kombinovanoho sudynno-imunnoho poshkodzhennya mozku. Opubl. Patent Ukrayiny № 36843. 2008 zhovt. 11. [in Ukrainian]
    • Mishchenko T·S, Dariy VI, Baranova KV. Vzayemozvyazok zapalnykh ta protyzapalnykh markeriv u khvorykh v hostromu periodi mozkovykh insultiv. Ukr. visnyk psykhonevrolohiyi. 2014; 22(2,79): 16-18. [in Ukrainian]
    • Yaremenko LM, Hrabovyy OM. Stan populyatsiyi limfotsytiv pry modelyuvanni porushen krovoobihu u liviy pivkuli holovnoho mozku u shchuriv ta yoho korektsiya. Imunolohiya ta alerholohiya. 2009; 1: 40-44.5. 5. Diamond B, Honig G, Mader S, et al. Brain-reactive antibodies and disease. Annu. Rev. Immunol., 2013; 31: 345-385. [in Ukrainian]
    • Irani S, Lang B. Autoantibody-mediated disorders of the central nervous system. Autoimmunity. 2008; 41(1): 55-65.
    • Lalancette-Hébert M, Swarup V, Beaulieu J, et al. Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. J. Neurosci. 2012; 32(30): 10383-10395.
    • Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 2009; 15: 192-199.
    • Stolp HB, Dziegielewska KM. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol. Appl. Neurobiol. 2009; 35: 132-146.
    • Walsh JT, Zheng J, Smirnov I, et al., Regulatory T cells in central nervous system injury: a double-edged sword. J. Immunol. 2014; 193(10): 5013-5022.
    • Yaremenko LM, Grabovyi OM. Influence of sensitization with brain antigen sensitization on the condition of cerebral cortex sensomotor neuroglial elements of their immunohistochemical detection. Deutscher Wissenschaftsherold. 2016; 2: 6-9.
    • Yaremenko LM, Grabovyi OM. Reactions of Microglial Cells in the Sensorimotor Cortex of Rats after Transient Ischemia. Neurophysiology. 2017; 49(2): 107–112.
    Publication of the article «World of Medicine and Biology» №3(65), 2018 year, 205-210 pages, index UDK 616.831-005.4-039:611.813.1:612.017.1:57.084
    DOI 10.26724/2079-8334-2018-3-65-205-210